Article info
THURSDAY, 14 JUNE 2018
Treatments: friend or foe?
OP0193 Tocilizumab and the risk for cardiovascular disease events among rheumatoid arthritis patients: a direct comparison in real world setting
Citation
OP0193 Tocilizumab and the risk for cardiovascular disease events among rheumatoid arthritis patients: a direct comparison in real world setting
Publication history
- First published June 12, 2018.
Online issue publication
January 09, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions